Calamos Advisors’s Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 NFYS.WS Stock Holding History

Calamos Advisors’s Portfolio NFYS.WS Stock Details NFYS.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-625,000	Closed	-$26.6K	–	1031
2024 Q2	$26.6K	Hold	625,000	–	–	﹤0.01%	843
2024 Q1	$36.7K	Hold	625,000	–	–	﹤0.01%	831
2023 Q4	$31.3K	Hold	625,000	–	–	﹤0.01%	788
2023 Q3	$52.8K	Hold	625,000	–	–	﹤0.01%	781
2023 Q2	$29.3K	Hold	625,000	–	–	﹤0.01%	840
2023 Q1	$75K	Hold	625,000	–	–	﹤0.01%	910
2022 Q4	$50K	Hold	625,000	–	–	﹤0.01%	983
2022 Q3	$78K	Buy	+625,000	New	+$77.4K	﹤0.01%	1081

Other funds holding NFYS.WS

CSD

Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Calamos Advisors's NFYS.WS Position: Q3 2024 in Review

Calamos Advisors sold out of Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (NFYS.WS) in Q3 2024, closing a stake of 625,000 shares — an estimated $26.6K sold.

Calamos Advisors first reported a position in NFYS.WS in Q3 2022 and held it in 8 quarters. The position peaked at $78K in Q3 2022. 5 funds tracked by Wall St. Rank hold NFYS.WS as of Q3 2024.

Calamos Advisors reported no remaining Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2024 after selling out during the quarter.
Calamos Advisors sold 625,000 Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2024, an estimated $26.6K.
Calamos Advisors first reported a position in Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2022 and held it in 8 quarters.
Calamos Advisors's Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $78K in Q3 2022.
5 funds tracked by Wall St. Rank held Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2024.

Based on Calamos Advisors's 13F filing for Q3 2024, filed 7 Nov 2024.